{
    "2018-08-27": [
        [
            {
                "time": "2018-07-03",
                "original_text": "Novartis' CAR-T Therapy Kymriah Gets Approval in Europe",
                "features": {
                    "keywords": [
                        "Novartis",
                        "CAR-T",
                        "Kymriah",
                        "Approval",
                        "Europe"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "Novartis wins EU approval for blood cancer therapy Kymriah",
                "features": {
                    "keywords": [
                        "Novartis",
                        "EU",
                        "approval",
                        "blood cancer",
                        "therapy",
                        "Kymriah"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "5 Reasons Why You Should Add Lilly Stock to Your Portfolio",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Stock",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "Ocrevus Could Boost Rocheâ€™s Revenue Growth in 2018 and Beyond",
                "features": {
                    "keywords": [
                        "Ocrevus",
                        "Roche",
                        "Revenue Growth",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-02",
                "original_text": "The Swiss Stock Market Climbed At The Start Of The Week",
                "features": {
                    "keywords": [
                        "Swiss Stock Market",
                        "Climbed",
                        "Start Of The Week"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "Novartis to boost ability to manufacture new cancer drug in Europe",
                "features": {
                    "keywords": [
                        "Novartis",
                        "manufacture",
                        "cancer drug",
                        "Europe"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "Novartis's Kymriah wins EU approval for blood cancer treatment",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Kymriah",
                        "EU",
                        "approval",
                        "blood cancer",
                        "treatment"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-03",
                "original_text": "Novartis Reports European Commission Approval Of Kymriah CAR-T Cell Therapy",
                "features": {
                    "keywords": [
                        "Novartis",
                        "European Commission",
                        "Approval",
                        "Kymriah",
                        "CAR-T",
                        "Cell Therapy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}